LSD1-IN-26
LSD1-IN-26 (compound 12u) is a potent LSD1 inhibitor, with an IC50 of 25.3 nM. LSD1-IN-26 also inhibits MAO-A (IC50=1234.57 nM) and MAO-B (IC50=3819.27 nM). LSD1-IN-26 significantly induces apoptosis in MGC-803 cells. LSD1-IN-26 can be used for gastric cancer research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3041141-72-1
- Formule: C27H25Cl2F2N3O
- Masse moléculaire:516.41
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform Caspase
More
Activité biologique
Description
IC50 & Target
|
LSD1 25.3 ± 1.4 nM (IC50) |
MAO-A 1234.57 nM (IC50) |
MAO-B 3819.27 nM (IC50) |
Bcl-2 |
cIAP-1 |
Caspase-3 |
Caspase-9 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HCT-116 | IC50 |
16.3 μM
Compound: 12u
|
Antiproliferative activity against human HCT-116 cells incubated for 48 hrs measured by MTT assay
Antiproliferative activity against human HCT-116 cells incubated for 48 hrs measured by MTT assay
|
[PMID: 36881982] |
| KYSE-450 | IC50 |
22.8 μM
Compound: 12u
|
Antiproliferative activity against human KYSE-450 cells incubated for 48 hrs measured by MTT assay
Antiproliferative activity against human KYSE-450 cells incubated for 48 hrs measured by MTT assay
|
[PMID: 36881982] |
| MGC-803 | IC50 |
14.3 μM
Compound: 12u
|
Antiproliferative activity against human MGC-803 cells incubated for 48 hrs measured by MTT assay
Antiproliferative activity against human MGC-803 cells incubated for 48 hrs measured by MTT assay
|
[PMID: 36881982] |
In Vitro
LSD1-IN-26 (compound 12u) shows the high potency against MGC-803, KYSE450 and HCT-116 cells with IC50 values of 14.3±1.18, 22.8±1.45 and 16.3±2.22 μM, respectively, which is more potent than that of GSK-LSD1 (HY-100546) (IC50 > 64 μM) and GSK-2879552 (HY-18632) (IC50 > 64 μM)[1].
LSD1-IN-26 (0-24 μM, 48 h) induces the accumulation of H3K4 Me1/2 and H3K9 Me2/3 and the decrease of Bcl-2 and c-IAP1[1].
LSD1-IN-26 (0-24 μM, 48 h) induces apoptosis and differentiation, and inhibits migration and cell stemness[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MGC-803 cells
-
Concentration:0, 8, 16, 24 μM
-
Incubation Time:48 h
-
Result:Effectively up-regulated the substrate proteins of LSD1, thereby significantly increasing the expression levels of mono-/bi-methylation of H3K4 and H3K9. Dose-dependently induced the decrease of expression levels of anti-apoptotic proteins Bcl-2 and c-IAP1, and the cleavage of apoptotic executive proteins Caspase3 and Caspase9.
Chemical Information
-
CAS No. 3041141-72-1
-
Masse moléculaire 516.41
-
Formule C27H25Cl2F2N3O
-
SMILES
O=C(N1CCN(CC1)C2=CC(Cl)=C(C=C2)Cl)C3=CC=CC(CN[C@@H]4C[C@H]4C5=CC=C(C(F)=C5)F)=C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Detection of Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)